Overview

The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial

Status:
Terminated
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy and safety of testosterone supplementation on functional capacity, biomarkers, quality of life and clinical outcomes for patients with heart failure.
Phase:
Phase 2
Details
Lead Sponsor:
University of Alberta
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate